	Who Truly Benefits from Anti-EGFR Rechallenge in Metastatic Colorectal Cancer? From Clinical Enrichment to ctDNA-Guided Molecular Hyperselection. J Gastrointest Cancer Sagawa T, Fujikawa K. PMID: 42240876 [PubMed - in process]
	Early-onset colorectal cancer: epidemiology, risk factors, and implications for clinical practice. Clin Transl Oncol Vitiello A, Zovi A. PMID: 42240810 [PubMed - as supplied by publisher]
	Efficacy and safety of trastuzumab deruxtecan in the treatment of HER2-positive advanced or metastatic gastric or gastroesophageal cancer: a meta-analysis of single-arm trials. Clin Transl Oncol Vatvani AD, Lazarus G, Al Jabiri R, Shabarek N. PMID: 42240809 [PubMed - as supplied by publisher]
	Diagnostic performance of LINE-1 repetitive elements in stool DNA for non-invasive detection of colorectal cancer. Clin Transl Oncol Karimi A, Taghizadeh-Teymorloei M, Ahangarzadeh Rezaee M, Matin S, Roosta Y, Alizadeh L, Dastgiri S, Bagheri A, Entezar Mahdi R. PMID: 42240808 [PubMed - as supplied by publisher]
	Therapeutic potential of targeting macrophage polarization in metastatic gastric cancer: a review on core mechanisms and clinical progress. Clin Transl Oncol Gong N, Qin G, Sun J, Shen S, Zhang X, Lu M. PMID: 42240805 [PubMed - as supplied by publisher]
	Beyond Sidedness: DNA Methylation as a Biomarker to Refine Anti-EGFR Treatment Selection in RAS/BRAF Wild-type Metastatic Colorectal Cancer. J Gastrointest Cancer Sagawa T, Nagashima H, Fujikawa K. PMID: 42240732 [PubMed - in process]
	Comparison of oncological outcomes between robotic and laparoscopic surgeries for gastric cancer: a multi-institutional cohort study in Japan. Gastric Cancer Fujita H, Nishigori T, Yamashita Y, Hosogi H, Kanaya S, Yamamoto M, Kinjo Y, Kondo M, Hata H, Kawada H, Matsuo K, Itami A, Hirai K, Kawamura Y, Manaka D, Nakajima S, Okabe H, Toda K, Tanaka E, Ito T, Miki A, Kawaguchi K, Mizuno R, Sakaguchi M, Okumura S, Hisamori S, Tsunoda S, Hida K, Ueno K, Tanaka S, Obama K, Kyoto Esophageal, Gastric Surgery Study Group. PMID: 42240715 [PubMed - as supplied by publisher]
	"You lose a day for every appointment": A qualitative study of how rural versus urban residence shapes cancer care experiences in Northeast Scotland. Support Care Cancer Carriere R, Adam R, Samuel L, Murchie P. PMID: 42240672 [PubMed - in process]
	Risk Factors for Subsequent Primary Cancers in Colorectal Cancer Survivors: A Systematic Review and Meta-analysis. Cancer Epidemiol Biomarkers Prev Aung YK, Zhang Y, Baxter NN, Jenkins MA, Win AK. PMID: 42240466 [PubMed - as supplied by publisher]
	Retrospective Cohort Study of Treatment Patterns and Outcomes for Patients With Locally Advanced Rectal Cancer Across Three Metropolitan Hospitals in Brisbane. Asia Pac J Clin Oncol Macilwraith P, Turner C, Roberts K, Bigby K, Kang S, Wyld D, Burge M, Eastgate M. PMID: 42240032 [PubMed - as supplied by publisher]
	Global, regional, and national burden of early-onset and late-onset colorectal cancer, 1990-2021: a comparative analysis for the Global Burden of Disease Study 2021. Future Sci OA Li X, Du H, Liao Q, Zhu Z, Niu H, Liu G. PMID: 42240008 [PubMed]
	Bridging the Evidence Gap: A Retrospective Lens on Survival and Treatment Patterns in Older Patients With Colorectal Cancer. Saudi Med J Tashkandi EM. PMID: 42239915 [PubMed - in process]
	An emerging targeted strategy for gastric cancer: the multi-pathway regulatory potential of Chinese medicine monomers. Front Oncol Chen J, Pan B, Cao X, Li Y, Tu Z, Ma C, Guo J. PMID: 42239904 [PubMed]
	RBBP6 and cancer: from molecular mechanisms to clinical implications. Front Oncol Ubanako PN, Nweke EE, Nsingwane Z, Monchusi B, Penny C. PMID: 42239902 [PubMed]
	Integrative omics identify NID2 as a therapeutic target linking depression and colorectal cancer in humans. iScience Huang L, Wang J, Tian H, Wang W, Nie Z, Cui X, Zhang L, Jin Y, Ding Y, Liu Z, Yu H, Wu L. PMID: 42239723 [PubMed]
	Integrated multi-omics characterization of SPTBN2 overexpression reveals its pro-tumorigenic role and immune microenvironment remodeling in colorectal cancer. Front Cell Dev Biol Chen C, Hao G, Cheng Z, Wang M, Sun F, Huang Y. PMID: 42238893 [PubMed]
	Design and preliminary report of a randomized phase IIb clinical trial of multitargeted recombinant adenovirus 5 vaccines against CEA, MUC1, and brachyury (Tri-Ad5) and the IL-15 receptor superagonist nogapendekin alfa inbakicept in Lynch syndrome (TRIAD5-Plus): the first cross-network trial of the Cancer Prevention Clinical Trials Network (CP-CTNet). Front Immunol Bansal A, Stoffel EM, Lim R, Stanich PP, Patel SG, Burke CA, Hall MJ, Singh A, Boardman LA, Samadder NJ, Ballestar V, Muller C, Scott AJ, Benante KA, Xu Y, Eickhoff J, Hyun M, Zaborek J, Aquila L, Umar A, Szabo E, Della'Zanna G, Richmond E, Bengtson L, Schlom J, Donahue RN, Toney NJ, Horn LA, Palena C, Gulley JL, Samaddar S, Moore DF Jr, Sharma P, Madan R, Hurley KE, Soon-Shiong P, Gabitzsch E, Sender L, Brenner D, Schuetze S, Djuric Z, Barroilhet LM, Thompson P, Bauman J, Khan SA, Vilar E. PMID: 42238576 [PubMed - in process]
	Autophagy as a therapeutic target for cisplatin-resistant gastric cancer. Genes Dis Wei L, Zhou Y, Li J, Qi H, Wang S. PMID: 42238312 [PubMed]
	Large-scale Searching for Causal Relationships of Body Mass Index Bridged Modifiable Lifestyle Factors on Colorectal Cancer Risk: A phenome-Wide Mendelian Randomization Study. Phenomics Shao M, Wang W, Li H, Chen S, Liu X, Ji H, Wang M, Xin J, Du M. PMID: 42238040 [PubMed]
	Social Support and Psychological Capital in Older Adults with Esophageal and Gastric Cancer: A Cross-Sectional Study. Cancer Manag Res Dehghan AH, Tabatabaei MS, Mottershead R, Ghane G. PMID: 42237985 [PubMed]

Articles 1 - 20 / 240469

Page 1 of 12024



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy